Regarding PSMA-PET for prostate cancer, several standardized evaluation criteria have recently been proposed [216,217,218,219] with the aim of improving inter-reader agreement [219] and to aid inexperienced readers [220]. This evidence concerns the gene FOLH1 and prostate carcinoma.